General Information of the Compound
Compound ID
CP0173361
Compound Name
N-[[3-(cyclopenten-1-yl)phenyl]methyl]-2-(2,3-dihydro-1,4-benzodioxin-5-yloxy)ethanamine
    Show/Hide
Structure
Formula
C22H25NO3
Molecular Weight
351.446
Canonical SMILES
C(COc1cccc2OCCOc12)NCc1cccc(c1)C1=CCCC1
    Show/Hide
InChI
InChI=1S/C22H25NO3/c1-2-7-18(6-1)19-8-3-5-17(15-19)16-23-11-12-24-20-9-4-10-21-22(20)26-14-13-25-21/h3-6,8-10,15,23H,1-2,7,11-14,16H2
    Show/Hide
InChIKey
PTSYEFRBIUQVOF-UHFFFAOYSA-N
Physicochemical Property
logP
4.1937
Rotatable Bonds
7
Heavy Atom Count
26
Polar Areas
39.72
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16109486
SID: 24756273
ChEMBL ID
CHEMBL375297
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 6.457 nM
   TI
   LI
   LO
   TS